Application number | Title of the application | Filing Date | Status |
---|
Array
(
[id] => 9397046
[patent_doc_number] => 20140094452
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-03
[patent_title] => 'Rapid Onset Liquid Midazolam Composition for Buccal Administration'
[patent_app_type] => utility
[patent_app_number] => 13/875915
[patent_app_country] => US
[patent_app_date] => 2013-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6684
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13875915
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/875915 | Rapid Onset Liquid Midazolam Composition for Buccal Administration | May 1, 2013 | Abandoned |
Array
(
[id] => 9162136
[patent_doc_number] => 20130310413
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-21
[patent_title] => 'ABUSE-DETERRENT DRUG FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 13/870690
[patent_app_country] => US
[patent_app_date] => 2013-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8041
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13870690
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/870690 | Abuse-deterrent drug formulations | Apr 24, 2013 | Issued |
Array
(
[id] => 9223774
[patent_doc_number] => 20140018549
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-16
[patent_title] => 'USE OF D-SERINE DERIVATIVES FOR THE TREATMENT OF ANXIETY DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 13/870819
[patent_app_country] => US
[patent_app_date] => 2013-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10340
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13870819
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/870819 | USE OF D-SERINE DERIVATIVES FOR THE TREATMENT OF ANXIETY DISORDERS | Apr 24, 2013 | Abandoned |
Array
(
[id] => 9016433
[patent_doc_number] => 20130231397
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-05
[patent_title] => 'SYNERGISTIC PREPARATIONS BASED ON MIXTURES OF GLYCEROL ETHER WITH AROMATIC ALCOHOL FOR CONTROLLING MYCOBACTERIA'
[patent_app_type] => utility
[patent_app_number] => 13/860696
[patent_app_country] => US
[patent_app_date] => 2013-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4622
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13860696
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/860696 | Synergistic preparations based on mixtures of glycerol ether with aromatic alcohol for controlling mycobacteria | Apr 10, 2013 | Issued |
Array
(
[id] => 10263261
[patent_doc_number] => 20150148258
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-28
[patent_title] => 'METHOD FOR SIMULTANEOUS DETECTION, RECOVERY, IDENTIFICATION AND COUNTING OF MICROORGANISMS AND DEVICES FOR THE IMPLEMENTATION OF SAID METHOD'
[patent_app_type] => utility
[patent_app_number] => 14/389568
[patent_app_country] => US
[patent_app_date] => 2013-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15551
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14389568
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/389568 | METHOD FOR SIMULTANEOUS DETECTION, RECOVERY, IDENTIFICATION AND COUNTING OF MICROORGANISMS AND DEVICES FOR THE IMPLEMENTATION OF SAID METHOD | Mar 26, 2013 | Abandoned |
Array
(
[id] => 9108277
[patent_doc_number] => 20130281409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-24
[patent_title] => 'Myelin Sheath Fatty Acids that Resolve Neuroinflammation'
[patent_app_type] => utility
[patent_app_number] => 13/847364
[patent_app_country] => US
[patent_app_date] => 2013-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 16591
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13847364
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/847364 | Myelin Sheath Fatty Acids that Resolve Neuroinflammation | Mar 18, 2013 | Abandoned |
Array
(
[id] => 8977399
[patent_doc_number] => 20130210829
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-15
[patent_title] => 'APPLICATION OF 5-HT6 RECEPTOR ANTAGONISTS FOR THE ALLEVIATION OF COGNITIVE DEFICITS OF DOWN SYNDROME'
[patent_app_type] => utility
[patent_app_number] => 13/837887
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 10487
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13837887
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/837887 | Application of 5-HT6 receptor antagonists for the alleviation of cognitive deficits of down syndrome | Mar 14, 2013 | Issued |
Array
(
[id] => 9951234
[patent_doc_number] => 09000021
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-04-07
[patent_title] => 'Method of treating bendamustine-responsive conditions in patients requiring reduced volumes for administration'
[patent_app_type] => utility
[patent_app_number] => 13/838267
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4200
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13838267
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/838267 | Method of treating bendamustine-responsive conditions in patients requiring reduced volumes for administration | Mar 14, 2013 | Issued |
Array
(
[id] => 10082548
[patent_doc_number] => 09119878
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-09-01
[patent_title] => 'Extended-release formulation for reducing the frequency of urination and method of use thereof'
[patent_app_type] => utility
[patent_app_number] => 13/828778
[patent_app_country] => US
[patent_app_date] => 2013-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 28241
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13828778
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/828778 | Extended-release formulation for reducing the frequency of urination and method of use thereof | Mar 13, 2013 | Issued |
Array
(
[id] => 9823627
[patent_doc_number] => 08933112
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-01-13
[patent_title] => 'Topical liquid to ameliorate pain and promote healing of burn-injured skin'
[patent_app_type] => utility
[patent_app_number] => 13/799113
[patent_app_country] => US
[patent_app_date] => 2013-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 6627
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13799113
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/799113 | Topical liquid to ameliorate pain and promote healing of burn-injured skin | Mar 12, 2013 | Issued |
Array
(
[id] => 9054020
[patent_doc_number] => 20130251734
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-26
[patent_title] => 'USE OF TAM RECEPTOR INHIBITORS AS ANTIMICROBIALS'
[patent_app_type] => utility
[patent_app_number] => 13/790191
[patent_app_country] => US
[patent_app_date] => 2013-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 25613
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13790191
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/790191 | Use of TAM receptor inhibitors as antimicrobials | Mar 7, 2013 | Issued |
Array
(
[id] => 9370962
[patent_doc_number] => 20140080834
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-20
[patent_title] => 'INHIBITION OF ADAPTOR ASSOCIATED KINASE 1 FOR THE TREATMENT OF PAIN'
[patent_app_type] => utility
[patent_app_number] => 13/786575
[patent_app_country] => US
[patent_app_date] => 2013-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 21311
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13786575
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/786575 | INHIBITION OF ADAPTOR ASSOCIATED KINASE 1 FOR THE TREATMENT OF PAIN | Mar 5, 2013 | Abandoned |
Array
(
[id] => 8976095
[patent_doc_number] => 20130209525
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-15
[patent_title] => 'CONTROLLED RELEASE FORMULATIONS OF OPIOID AND NONOPIOID ANALGESICS'
[patent_app_type] => utility
[patent_app_number] => 13/781420
[patent_app_country] => US
[patent_app_date] => 2013-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 48204
[patent_no_of_claims] => 121
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13781420
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/781420 | CONTROLLED RELEASE FORMULATIONS OF OPIOID AND NONOPIOID ANALGESICS | Feb 27, 2013 | Abandoned |
Array
(
[id] => 10069584
[patent_doc_number] => 09107919
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-08-18
[patent_title] => 'Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration'
[patent_app_type] => utility
[patent_app_number] => 13/775906
[patent_app_country] => US
[patent_app_date] => 2013-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 41054
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13775906
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/775906 | Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration | Feb 24, 2013 | Issued |
Array
(
[id] => 8892328
[patent_doc_number] => 20130165512
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-27
[patent_title] => 'COMPOSITIONS COMPRISING A RETINOID AND AN NFkB-INHIBITOR AND THEIR METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 13/773768
[patent_app_country] => US
[patent_app_date] => 2013-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7395
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13773768
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/773768 | Compositions comprising a retinoid and an NFkB-inhibitor and their methods of use | Feb 21, 2013 | Issued |
Array
(
[id] => 8884830
[patent_doc_number] => 20130158014
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-20
[patent_title] => 'METHOD FOR TREATING DISEASES ASSOCIATED WITH ALTERATIONS IN CELLULAR INTEGRITY USING RHO KINASE INHIBITOR COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/763548
[patent_app_country] => US
[patent_app_date] => 2013-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 35590
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13763548
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/763548 | METHOD FOR TREATING DISEASES ASSOCIATED WITH ALTERATIONS IN CELLULAR INTEGRITY USING RHO KINASE INHIBITOR COMPOUNDS | Feb 7, 2013 | Abandoned |
Array
(
[id] => 8866680
[patent_doc_number] => 20130150383
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-13
[patent_title] => 'NOVEL COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/760423
[patent_app_country] => US
[patent_app_date] => 2013-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23954
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13760423
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/760423 | NOVEL COMPOUNDS | Feb 5, 2013 | Abandoned |
Array
(
[id] => 10857631
[patent_doc_number] => 08883831
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-11-11
[patent_title] => 'Compositions and methods for minimizing or reversing agonist-induced desensitization'
[patent_app_type] => utility
[patent_app_number] => 13/758569
[patent_app_country] => US
[patent_app_date] => 2013-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9688
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13758569
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/758569 | Compositions and methods for minimizing or reversing agonist-induced desensitization | Feb 3, 2013 | Issued |
13/751169 | Use Of (1R,5S)-(+)-(Napthalen-2-yl)-3-Azabicyclo[3.1.0]Hexane In The Treatment Of Conditions Affected By Monoamine Neurotransmitters | Jan 27, 2013 | Abandoned |
Array
(
[id] => 8822309
[patent_doc_number] => 20130123354
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-16
[patent_title] => 'SOLUBLE GUANYLATE CYCLASE (SGC) MODULATORS FOR TREATMENT OF LIPID RELATED DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 13/736291
[patent_app_country] => US
[patent_app_date] => 2013-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15777
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13736291
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/736291 | SOLUBLE GUANYLATE CYCLASE (SGC) MODULATORS FOR TREATMENT OF LIPID RELATED DISORDERS | Jan 7, 2013 | Abandoned |